Certain survival benefits may be brought to patients with advanced GC by the combination of chemotherapy and immunotherapy.16 It was considered by Erdogdu Et Al.17 that the poor prognosis of advanced GC has a bearing on the increased expression of PDL-1 in cancer cells. Here, CD274 is linked to cancer.